Karl Podratz

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Concepts & Ideas

Disorders

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Aletti Giovanni D; Powless Cecelia; Bakkum-Gamez Jamie; Wilson Timothy O; Podratz Karl C; Cliby William A
Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy.
Uccella Stefano; Podratz Karl C; Aletti Giovanni D; Mariani Andrea
Re: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Mariani Andrea; Dowdy Sean C; Podratz Karl C
New surgical staging of endometrial cancer: 20 years later.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Karl Podratz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Aletti Giovanni D; Powless Cecelia; Bakkum-Gamez Jamie; Wilson Timothy O; Podratz Karl C; Cliby William A
Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy.
Gynecologic oncology 2009;114(1):32-6.
2009: Uccella Stefano; Podratz Karl C; Aletti Giovanni D; Mariani Andrea
Re: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Journal of the National Cancer Institute 2009;101(12):897-8; author reply 898-9.
2009: Mariani Andrea; Dowdy Sean C; Podratz Karl C
New surgical staging of endometrial cancer: 20 years later.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2009;105(2):110-1.
2009: Aletti Giovanni D; Dowdy Sean C; Gostout Bobbie S; Jones Monica B; Stanhope Robert C; Wilson Timothy O; Podratz Karl C; Cliby William A
Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience.
Journal of the American College of Surgeons 2009;208(4):614-20.
2009: Uccella Stefano; Podratz Karl C; Aletti Giovanni D; Mariani Andrea
Lymphadenectomy in endometrial cancer.
Lancet 2009;373(9670):1170; author reply 1170-1.
2009: Thomas M Bijoy; Keeney Gary L; Podratz Karl C; Dowdy Sean C
Endometrial stromal sarcoma: treatment and patterns of recurrence.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(2):253-6.
2009: Konecny G E; Santos L; Winterhoff B; Hatmal M; Keeney G L; Mariani A; Jones M; Neuper C; Thomas B; Muderspach L; Riehle D; Wang H-J; Dowdy S; Podratz K C; Press M F
HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer.
British journal of cancer 2009;100(1):89-95.
2009: Baron Andre T; Lafky Jacqueline M; Boardman Cecelia H; Cora Elsa M; Buenafe Marites C; Liu Dachao; Rademaker Alfred; Fishman David A; Podratz Karl C; Reiter Jill L; Maihle Nita J
Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer.
Cancer treatment and research 2009;149():189-202.
2008: Dowdy Sean C; Aletti Giovanni; Cliby William A; Podratz Karl C; Mariani Andrea
Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial cancer.
Gynecologic oncology 2008;111(3):418-24.
2008: Brown Jones Monica; Neuper Christina; Clayton Amy; Mariani Andrea; Konecny Gottfried; Thomas M Bijoy; Keeney Gary; Hartmann Lynn; Podratz Karl C
Rationale for folate receptor alpha targeted therapy in "high risk" endometrial carcinomas.
International journal of cancer. Journal international du cancer 2008;123(7):1699-703.
2008: Thomas M Bijoy; Wright Jason D; Leiser Aliza L; Chi Dennis S; Mutch David G; Podratz Karl C; Dowdy Sean C
Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era.
Gynecologic oncology 2008;109(3):335-9.
2008: Konecny Gottfried E; Agarwal Rachana; Keeney Gary A; Winterhoff Boris; Jones Monica Brown; Mariani Andrea; Riehle Darren; Neuper Christina; Dowdy Sean C; Wang He-Jing; Morin Patrice J; Podratz Karl C
Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer.
Gynecologic oncology 2008;109(2):263-9.
2008: Mariani Andrea; Dowdy Sean C; Cliby William A; Gostout Bobbie S; Jones Monica B; Wilson Timothy O; Podratz Karl C
Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.
Gynecologic oncology 2008;109(1):11-8.
2008: Konecny G E; Venkatesan N; Yang G; Dering J; Ginther C; Finn R; Rahmeh M; Fejzo M Schoenberg; Toft D; Jiang S-W; Slamon D J; Podratz K C
Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells.
British journal of cancer 2008;98(6):1076-84.
2008: Thomas M; Mariani A; Wright J D; Madarek E O S; Powell M A; Mutch D G; Podratz K C; Dowdy S C
Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review.
Gynecologic oncology 2008;108(2):293-7.
2007: Aletti Giovanni D; Dowdy Sean C; Podratz Karl C; Cliby William A
Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer.
American journal of obstetrics and gynecology 2007;197(6):676.e1-7.
2007: Dowdy Sean C; Mariani Andrea; Bakkum Jamie N; Cliby William A; Keeney Gary L; Podratz Karl C
Treatment of pulmonary recurrences in patients with endometrial cancer.
Gynecologic oncology 2007;107(2):242-7.
2007: Thomas M Bijoy; Mariani Andrea; Cliby William A; Keeney Gary L; Podratz Karl C; Dowdy Sean C
Role of cytoreduction in stage III and IV uterine papillary serous carcinoma.
Gynecologic oncology 2007;107(2):190-3.
2007: Thomas M Bijoy; Mariani Andrea; Cliby William A; Keeney Gary A; Podratz Karl C; Dowdy Sean C
Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
Gynecologic oncology 2007;107(2):186-9.
2007: Zhou X Clare; Dowdy Sean C; Podratz Karl C; Jiang Shi-Wen
Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment.
Gynecologic oncology 2007;107(1):143-53.
2007: Aletti Giovanni D; Santillan Antonio; Eisenhauer Eric L; Hu Jae; Aletti Giacomo; Podratz Karl C; Bristow Robert E; Chi Dennis S; Cliby William A
A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.
Gynecologic oncology 2007;107(1):99-106.
2007: Huh W K; Straughn J M; Mariani A; Podratz K C; Havrilesky L J; Alvarez-Secord A; Gold M A; McMeekin D S; Modesitt S; Cooper A L; Powell M A; Mutch D G; Nag S; Alvarez R D; Cohn D E
Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(4):886-9.
2007: Gonzalez Bosquet Jesus; Magrina Javier F; Magtibay Paul M; Gaffey Thomas A; Cha Stephen S; Jones Monica B; Podratz Karl C; Cliby William A
Patterns of inguinal groin metastases in squamous cell carcinoma of the vulva.
Gynecologic oncology 2007;105(3):742-6.
2007: Cohn David E; Woeste Emily M; Cacchio Stacey; Zanagnolo Vanna L; Havrilesky Laura J; Mariani Andrea; Podratz Karl C; Huh Warner K; Whitworth Jenny M; McMeekin D Scott; Powell Matthew A; Boyd Emily; Phillips Gary S; Fowler Jeffrey M
Clinical and pathologic correlates in surgical stage II endometrial carcinoma.
Obstetrics and gynecology 2007;109(5):1062-7.
2007: Jiang Shujuan; Dowdy Sean C; Meng Xue W; Wang Zhaoyu; Jones Monica B; Podratz Karl C; Jiang Shi-Wen
Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells.
Gynecologic oncology 2007;105(2):493-500.
2007: Aletti Giovanni D; Dowdy Sean C; Podratz Karl C; Cliby William A
Analysis of factors impacting operability in stage IV ovarian cancer: rationale use of a triage system.
Gynecologic oncology 2007;105(1):84-9.
2007: Aletti Giovanni D; Long Harry J; Podratz Karl C; Cliby William A
Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?
Gynecologic oncology 2007;104(1):212-6.
2006: Aletti Giovanni D; Dowdy Sean; Podratz Karl C; Cliby William A
Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
American journal of obstetrics and gynecology 2006;195(6):1862-8.
2006: Cliby William A; Aletti Giovanni D; Wilson Timothy O; Podratz Karl C
Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?
Gynecologic oncology 2006;103(3):797-801.
2006: Dowdy Sean C; Jiang Shujuan; Zhou X Clare; Hou Xiaonan; Jin Fan; Podratz Karl C; Jiang Shi-Wen
Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells.
Molecular cancer therapeutics 2006;5(11):2767-76.
2006: Aletti Giovanni D; Podratz Karl C; Jones Monica B; Cliby William A
Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer.
Journal of the American College of Surgeons 2006;203(4):521-6.
2006: Podratz Karl C
Quality improvement in gynecologic surgery: the new frontier.
American journal of obstetrics and gynecology 2006;195(4):891-5.
2006: Xiong Yuning; Dowdy Sean C; Eberhardt Norman L; Podratz Karl C; Jiang Shi-Wen
hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications.
Gynecologic oncology 2006;103(1):321-8.
2006: Magtibay Paul M; Adams Peter B; Silverman M Bradley; Cha Stephen S; Podratz Karl C
Splenectomy as part of cytoreductive surgery in ovarian cancer.
Gynecologic oncology 2006;102(2):369-74.
2006: Jones Monica Brown; Houwink Aletta P; Freeman Brandi K; Greenwood Tammy M; Lafky Jacqueline M; Lingle Wilma L; Berchuck Andrew; Maxwell G Lawrence; Podratz Karl C; Maihle Nita J
The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancer.
Journal of the Society for Gynecologic Investigation 2006;13(4):304-11.
2006: Mariani Andrea; Dowdy Sean C; Cliby William A; Haddock Michael G; Keeney Gary L; Lesnick Timothy G; Podratz Karl C
Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
Gynecologic oncology 2006;101(2):200-8.
2006: Dowdy Sean C; Mariani Andrea; Cliby William A; Haddock Michael G; Petersen Ivy A; Sim Franklin H; Podratz Karl C
Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes.
Gynecologic oncology 2006;101(2):280-6.
2006: Mariani Andrea; Sebo Thomas J; Cliby William A; Keeney Gary L; Riehle Darren L; Lesnick Timothy G; Podratz Karl C
Role of bcl-2 in endometrioid corpus cancer: an experimental study.
Anticancer research 2006;26(2A):823-7.
2006: Long Harry J; Nelimark Robert A; Podratz Karl C; Suman Vera; Keeney Gary L; Nikcevich Daniel A; Kugler John W; Rowland Kendrith M; Kardinal Carl G; Wos Edward J
Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
Gynecologic oncology 2006;100(3):501-5.
2006: Konecny Gottfried E; Pegram Mark D; Venkatesan Natarajan; Finn Richard; Yang Guorong; Rahmeh Martina; Untch Michael; Rusnak David W; Spehar Glenn; Mullin Robert J; Keith Barry R; Gilmer Tona M; Berger Mark; Podratz Karl C; Slamon Dennis J
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells.
Cancer research 2006;66(3):1630-9.
2006: Aletti Giovanni D; Dowdy Sean C; Podratz Karl C; Cliby William A
Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer.
Gynecologic oncology 2006;100(2):283-7.
2006: Magtibay P M; Salmon Z; Keeney G L; Podratz K C
Aggressive angiomyxoma of the female pelvis and perineum: a case series.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(1):396-401.
2006: Aletti Giovanni D; Dowdy Sean C; Gostout Bobbie S; Jones Monica B; Stanhope C Robert; Wilson Timothy O; Podratz Karl C; Cliby William A
Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
Obstetrics and gynecology 2006;107(1):77-85.
2006: Aletti Giovanni D; Gostout Bobbie S; Podratz Karl C; Cliby William A
Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon.
Gynecologic oncology 2006;100(1):33-7.
2006: Bosquet Jesus Gonzalez; Merideth Melissa A; Podratz Karl C; Nagorney David M
Hepatic resection for metachronous metastases from ovarian carcinoma.
HPB : the official journal of the International Hepato Pancreato Biliary Association 2006;8(2):93-6.
2005: Magtibay Paul M; Nyholm Jessica L; Hernandez Jose L; Podratz Karl C
Ovarian remnant syndrome.
American journal of obstetrics and gynecology 2005;193(6):2062-6.
2005: Xiong Yuning; Dowdy Sean C; Gonzalez Bosquet Jesus; Zhao Ying; Eberhardt Norman L; Podratz Karl C; Jiang Shi-Wen
Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines.
Gynecologic oncology 2005;99(1):135-41.
2005: Dowdy Sean C; Gostout Bobbie S; Shridhar Viji; Wu Xiaosheng; Smith David I; Podratz Karl C; Jiang Shi-Wen
Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines.
Gynecologic oncology 2005;99(1):126-34.
2005: Mariani Andrea; Sebo Thomas J; Katzmann Jerry A; Riehle Darren L; Dowdy Sean C; Keeney Gary L; Lesnick Timothy G; Podratz Karl C
HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature.
Anticancer research 2005;25(4):2921-7.
2005: Gonzalez Bosquet Jesus; Magrina Javier F; Gaffey Thomas A; Hernandez Jose L; Webb Maurice J; Cliby William A; Podratz Karl C
Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva.
Gynecologic oncology 2005;97(3):828-33.
2005: Mariani Andrea; Dowdy Sean C; Keeney Gary L; Haddock Michael G; Lesnick Timothy G; Podratz Karl C
Predictors of vaginal relapse in stage I endometrial cancer.
Gynecologic oncology 2005;97(3):820-7.
2005: Xiong Yuning; Dowdy Sean C; Podratz Karl C; Jin Fan; Attewell John R; Eberhardt Norman L; Jiang Shi-Wen
Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells.
Cancer research 2005;65(7):2684-9.
2005: Xiong Yuning; Dowdy Sean C; Xue Ailing; Shujuan Jiang; Eberhardt Norman L; Podratz Karl C; Jiang Shi-Wen
Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
Gynecologic oncology 2005;96(3):601-9.
2005: Mariani Andrea; Sebo Thomas J; Katzmann Jerry A; Roche Patrick C; Keeney Gary L; Lesnick Timothy G; Podratz Karl C
Endometrial cancer: can nodal status be predicted with curettage?
Gynecologic oncology 2005;96(3):594-600.
2005: Baron Andre T; Boardman Cecelia H; Lafky Jacqueline M; Rademaker Alfred; Liu Dachao; Fishman David A; Podratz Karl C; Maihle Nita J
Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(2):306-18.
2005: Jin Fan; Dowdy Sean C; Xiong Yuning; Eberhardt Norman L; Podratz Karl C; Jiang Shi-Wen
Up-regulation of DNA methyltransferase 3B expression in endometrial cancers.
Gynecologic oncology 2005;96(2):531-8.
2005: Dowdy Sean C; Metzinger Daniel S; Gebhart John B; Srivatsa Preeti; Haddock Michael G; Suman Vera J; Podratz Karl C
Salvage whole-abdominal radiation therapy after second-look laparotomy or secondary debulking surgery in patients with ovarian cancer.
Gynecologic oncology 2005;96(2):389-94.
2005: Dowdy Sean C; Mariani Andrea; Reinholz Monica M; Keeney Gary L; Spelsberg Thomas C; Podratz Karl C; Janknecht Ralf
Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer.
Gynecologic oncology 2005;96(2):368-73.
2004: Mariani Andrea; Dowdy Sean C; Keeney Gary L; Long Harry J; Lesnick Timothy G; Podratz Karl C
High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.
Gynecologic oncology 2004;95(1):120-6.
2004: Cliby William; Dowdy Sean; Feitoza Simone S; Gostout Bobbie S; Podratz Karl C
Diaphragm resection for ovarian cancer: technique and short-term complications.
Gynecologic oncology 2004;94(3):655-60.
2004: Jatoi Aminah; Podratz Karl C; Gill Paula; Hartmann Lynn C
Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer.
The journal of supportive oncology 2004;2(4):323-34; discussion 334-7.
2004: Croak Andrew J; Gebhart John B; Klingele Christopher J; Schroeder Georgene; Lee Raymond A; Podratz Karl C
Characteristics of patients with vaginal rupture and evisceration.
Obstetrics and gynecology 2004;103(3):572-6.
2004: Mariani Andrea; Keeney Gary L; Aletti Giacomo; Webb Maurice J; Haddock Michael G; Podratz Karl C
Endometrial carcinoma: paraaortic dissemination.
Gynecologic oncology 2004;92(3):833-8.
2003: Dowdy Sean C; Constantinou Costas L; Hartmann Lynn C; Keeney Gary L; Suman Vera J; Hillman David W; Podratz Karl C
Long-term follow-up of women with ovarian cancer after positive second-look laparotomy.
Gynecologic oncology 2003;91(3):563-8.
2003: Podratz Karl C; Mariani Andrea
Uterine papillary serous carcinomas: the exigency for clinical trials.
Gynecologic oncology 2003;91(3):461-2.
2003: Gonzalez Bosquet Jesus; Kinney Walter K; Russell Anthony H; Gaffey Thomas A; Magrina Javier F; Podratz Karl C
Risk of occult inguinofemoral lymph node metastasis from squamous carcinoma of the vulva.
International journal of radiation oncology, biology, physics 2003;57(2):419-24.
2003: Carley Michael E; Rickard David J; Gebhart John B; Webb Maurice J; Podratz Karl C; Spelsberg Thomas C
Distribution of estrogen receptors alpha and beta mRNA in mouse urogenital tissues and their expression after oophorectomy and estrogen replacement.
International urogynecology journal and pelvic floor dysfunction 2003;14(2):141-5.
2003: Mariani Andrea; Webb Maurice J; Keeney Gary L; Aletti Giacomo; Podratz Karl C
Endometrial cancer: predictors of peritoneal failure.
Gynecologic oncology 2003;89(2):236-42.
2003: Merideth Melissa A; Cliby William A; Keeney Gary L; Lesnick Timothy G; Nagorney David M; Podratz Karl C
Hepatic resection for metachronous metastases from ovarian carcinoma.
Gynecologic oncology 2003;89(1):16-21.
2003: Baron Andre T; Cora Elsa M; Lafky Jacqueline M; Boardman Cecelia H; Buenafe Marites C; Rademaker Alfred; Liu Dachao; Fishman David A; Podratz Karl C; Maihle Nita J
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(2):103-13.
2003: Mariani Andrea; Sebo Thomas J; Webb Maurice J; Riehle Darren; Katzmann Jerry A; Keeney Gary L; Roche Patrick C; Lesnick Timothy G; Podratz Karl C
Molecular and histopathologic predictors of distant failure in endometrial cancer.
Cancer detection and prevention 2003;27(6):434-41.
2002: Long Harry J; Rayson Sandra; Podratz Karl C; Abu-Ghazaleh Samir; Suman Vera; Hartmann Lynn C; Levitt Ralph; Nair Suresh; Hatfield Alan K; Knost James A
Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature.
American journal of clinical oncology 2002;25(6):547-51.
2002: Mariani Andrea; Webb Maurice J; Keeney Gary L; Lesnick Timothy G; Podratz Karl C
Surgical stage I endometrial cancer: predictors of distant failure and death.
Gynecologic oncology 2002;87(3):274-80.
2002: Mariani Andrea; Webb Maurice J; Keeney Gary L; Haddock Michael G; Aletti Giacomo; Podratz Karl C
Stage IIIC endometrioid corpus cancer includes distinct subgroups.
Gynecologic oncology 2002;87(1):112-7.
2002: Mariani Andrea; Webb Maurice J; Keeney Gary L; Aletti Giacomo; Podratz Karl C
Assessment of prognostic factors in stage IIIA endometrial cancer.
Gynecologic oncology 2002;86(1):38-44.
2002: Dowdy Sean C; Boardman Cecelia H; Wilson Timothy O; Podratz Karl C; Hartmann Lynn C; Long Harry J
Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer.
American journal of obstetrics and gynecology 2002;186(6):1167-73.
2002: Gostout Bobbie S; Cliby William A; Podratz Karl C
Prevention and management of acute intraoperative bleeding.
Clinical obstetrics and gynecology 2002;45(2):481-91.
2002: Mariani Andrea; Webb Maurice J; Keeney Gary L; Aletti Giacomo; Podratz Karl C
Predictors of lymphatic failure in endometrial cancer.
Gynecologic oncology 2002;84(3):437-42.
2002: Maihle N J; Baron A T; Barrette B A; Boardman C H; Christensen T A; Cora E M; Faupel-Badger J M; Greenwood T; Juneja S C; Lafky J M; Lee H; Reiter J L; Podratz K C
EGF/ErbB receptor family in ovarian cancer.
Cancer treatment and research 2002;107():247-58.
2001: Gebhart J B; Rickard D J; Barrett T J; Lesnick T G; Webb M J; Podratz K C; Spelsberg T C
Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women.
American journal of obstetrics and gynecology 2001;185(6):1325-30; discussion 1330-1.
2001: Baron A T; Lafky J M; Suman V J; Hillman D W; Buenafe M C; Boardman C H; Podratz K C; Perez E A; Maihle N J
A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(11):1175-85.
2001: Mariani A; Webb M J; Keeney G L; Calori G; Podratz K C
Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.
Gynecologic oncology 2001;83(1):72-80.
2001: Dowdy S C; O'Kane D J; Keeney G L; Boyd J; Podratz K C
Telomerase activity in sex cord-stromal tumors of the ovary.
Gynecologic oncology 2001;82(2):257-60.
2001: Mariani A; Webb M J; Keeney G L; Podratz K C
Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer.
Gynecologic oncology 2001;81(1):100-4.
2001: Mariani A; Webb M J; Keeney G L; Calori G; Podratz K C
Hematogenous dissemination in corpus cancer.
Gynecologic oncology 2001;80(2):233-8.
2001: Mariani A; Webb M J; Rao S K; Lesnick T G; Podratz K C
Significance of pathologic patterns of pelvic lymph node metastases in endometrial cancer.
Gynecologic oncology 2001;80(2):113-20.
2000: Mariani A; Nascimento A G; Webb M J; Sim F H; Podratz K C
Surgical management of desmoid tumors of the female pelvis.
Journal of the American College of Surgeons 2000;191(2):175-83.
2000: Mariani A; Sebo T J; Katzmann J A; Keeney G L; Roche P C; Lesnick T G; Podratz K C
Pretreatment assessment of prognostic indicators in endometrial cancer.
American journal of obstetrics and gynecology 2000;182(6):1535-44.
2000: Mariani A; Webb M J; Keeney G L; Haddock M G; Calori G; Podratz K C
Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?
American journal of obstetrics and gynecology 2000;182(6):1506-19.
2000: Gebhart J B; Roche P C; Keeney G L; Lesnick T G; Podratz K C
Assessment of inhibin and p53 in granulosa cell tumors of the ovary.
Gynecologic oncology 2000;77(2):232-6.
2000: Silverman M B; Roche P C; Kho R M; Keeney G L; Li H; Podratz K C
Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma.
Gynecologic oncology 2000;77(1):1-7.
2000: Mariani A; Webb M J; Galli L; Podratz K C
Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer.
Gynecologic oncology 2000;76(3):348-56.
2000: Magrina J F; Gonzalez-Bosquet J; Weaver A L; Gaffey T A; Leslie K O; Webb M J; Podratz K C
Squamous cell carcinoma of the vulva stage IA: long-term results.
Gynecologic oncology 2000;76(1):24-7.
1999: Ramsey P S; Podratz K C
Acute pancreatitis after gynecologic and obstetric surgery.
American journal of obstetrics and gynecology 1999;181(3):542-6.
1999: Podratz K C
Gynecologic oncology-on the eve of the new millennium.
Gynecologic oncology 1999;74(2):157-62.
1999: Villeneuve J B; Silverman M B; Alderete B; Cliby W A; Li H; Croghan G A; Podratz K C; Jenkins R B
Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancer.
Genes, chromosomes & cancer 1999;25(1):65-9.
1999: Baron A T; Lafky J M; Boardman C H; Balasubramaniam S; Suman V J; Podratz K C; Maihle N J
Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999;8(2):129-37.
1999: Magrina J F; Goodrich M A; Lidner T K; Weaver A L; Cornella J L; Podratz K C
Modified radical hysterectomy in the treatment of early squamous cervical cancer.
Gynecologic oncology 1999;72(2):183-6.
1998: Baron A T; Lafky J M; Connolly D C; Peoples J; O'Kane D J; Suman V J; Boardman C H; Podratz K C; Maihle N J
A sandwich type acridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human sera.
Journal of immunological methods 1998;219(1-2):23-43.
1998: Magrina J F; Gonzalez-Bosquet J; Weaver A L; Gaffey T A; Webb M J; Podratz K C; Cornella J L
Primary squamous cell cancer of the vulva: radical versus modified radical vulvar surgery.
Gynecologic oncology 1998;71(1):116-21.
1998: Gostout B S; Podratz K C; McGovern R M; Persing D H
Cervical cancer in older women: a molecular analysis of human papillomavirus types, HLA types, and p53 mutations.
American journal of obstetrics and gynecology 1998;179(1):56-61.
1998: Podratz K C
Gynecologic surgery: an imperiled ballet. Presidential address.
American journal of obstetrics and gynecology 1998;178(6):1229-34.
1997: Barrette B A; Srivatsa P J; Cliby W A; Keeney G L; Suman V J; Podratz K C; Roche P C
Overexpression of p34cdc2 protein kinase in epithelial ovarian carcinoma.
Mayo Clinic proceedings. Mayo Clinic 1997;72(10):925-9.
1997: Srivatsa P J; Cliby W A; Keeney G L; Suman V J; Harmsen W S; Ziesmer S C; Roche P C; Podratz K C
Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma.
Gynecologic oncology 1997;66(2):238-45.
1997: Garton G R; Gunderson L L; Webb M J; Wilson T O; Cha S S; Podratz K C
Intraoperative radiation therapy in gynecologic cancer: update of the experience at a single institution.
International journal of radiation oncology, biology, physics 1997;37(4):839-43.
1997: Haddock M G; Petersen I A; Webb M J; Wilson T O; Podratz K C; Gunderson L L
IORT for locally advanced gynecological malignancies.
Frontiers of radiation therapy and oncology 1997;31():256-9.
1996: Zanetta G; Keeney G L; Cha S S; Farr G H; Katzmann J A; Wieand H S; Edmonson J H; Podratz K C
Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survival.
American journal of obstetrics and gynecology 1996;175(5):1217-25.
1996: Evans M P; Podratz K C
Endometrial neoplasia: prognostic significance of ploidy status.
Clinical obstetrics and gynecology 1996;39(3):696-706.
1996: Zanetta G; Keeney G L; Cha S S; Wieand H S; Katzmann J A; Podratz K C
DNA index by flow cytometric analysis: an additional prognostic factor in advanced ovarian carcinoma without residual disease after primary operation.
Gynecologic oncology 1996;62(2):208-12.
1996: Hamel N W; Sebo T J; Wilson T O; Keeney G L; Roche P C; Suman V J; Hu T C; Podratz K C
Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma.
Gynecologic oncology 1996;62(2):192-8.
1996: Srivatsa P J; Cliby W A; Keeney G L; Dodson M K; Suman V J; Roche P C; Podratz K C
Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Gynecologic oncology 1996;60(3):363-72.
1996: Zanetta G M; Keeney G L; Kimlinger T K; Katzmann J A; Podratz K C
Concordance of DNA ploidy pattern as measured by flow cytometry in primary, metastatic, and persistent ovarian carcinoma.
Gynecologic oncology 1996;60(2):213-6.
1995: Dodson M K; Cliby W A; Pettavel P P; Keeney G L; Podratz K C
Female urethral adenocarcinoma: evidence for more than one tissue of origin?
Gynecologic oncology 1995;59(3):352-7.
1995: Magrina J F; Goodrich M A; Weaver A L; Podratz K C
Modified radical hysterectomy: morbidity and mortality.
Gynecologic oncology 1995;59(2):277-82.
1995: Cliby W A; Dodson M K; Podratz K C
Uterine prolapse complicated by endometrial cancer.
American journal of obstetrics and gynecology 1995;172(6):1675-80; discussion 1680-3.
1995: Lacy M Q; Hartmann L C; Keeney G L; Cha S C; Wieand H S; Podratz K C; Roche P C
c-erbB-2 and p53 expression in fallopian tube carcinoma.
Cancer 1995;75(12):2891-6.
1995: Zanetta G; Keeney G; Katzmann J; Podratz K C
Nuclear DNA content of persistent tumour lacks prognostic relevance for length of survival in patients undergoing second-look laparotomy for ovarian cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(6):1027-8.
1995: Kinney W K; Hodge D O; Egorshin E V; Ballard D J; Podratz K C
Surgical treatment of patients with stages IB and IIA carcinoma of the cervix and palpably positive pelvic lymph nodes.
Gynecologic oncology 1995;57(2):145-9.
1995: Kinney W K; Hodge D O; Egorshin E V; Ballard D J; Podratz K C
Identification of a low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment.
Gynecologic oncology 1995;57(1):3-6.
1994: Podratz K C; Cliby W A
Second-look surgery in the management of epithelial ovarian carcinoma.
Gynecologic oncology 1994;55(3 Pt 2):S128-33.
1994: Dodson M K; Cliby W A; Keeney G L; Peterson M F; Podratz K C
Skene's gland adenocarcinoma with increased serum level of prostate-specific antigen.
Gynecologic oncology 1994;55(2):304-7.
1994: Cliby W A; Dodson M K; Podratz K C
Cervical cancer complicated by pregnancy: episiotomy site recurrences following vaginal delivery.
Obstetrics and gynecology 1994;84(2):179-82.
1994: van Winter J T; Simmons P S; Podratz K C
Surgically treated adnexal masses in infancy, childhood, and adolescence.
American journal of obstetrics and gynecology 1994;170(6):1780-6; discussion 1786-9.
1994: Srivatsa P J; Keeney G L; Podratz K C
Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome.
Gynecologic oncology 1994;53(2):256-64.
1994: Dodson M K; Cliby W A; Xu H J; DeLacey K A; Hu S X; Keeney G L; Li J; Podratz K C; Jenkins R B; Benedict W F
Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
Cancer research 1994;54(3):610-3.
1994: Hartmann L C; Podratz K C; Keeney G L; Kamel N A; Edmonson J H; Grill J P; Su J Q; Katzmann J A; Roche P C
Prognostic significance of p53 immunostaining in epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):64-9.
1993: Dodson M K; Hartmann L C; Cliby W A; DeLacey K A; Keeney G L; Ritland S R; Su J Q; Podratz K C; Jenkins R B
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Cancer research 1993;53(19):4456-60.
1993: Cliby W; Sarkar G; Ritland S R; Hartmann L; Podratz K C; Jenkins R B
Absence of prohibitin gene mutations in human epithelial ovarian tumors.
Gynecologic oncology 1993;50(1):34-7.
1993: Leiserowitz G S; Harris S A; Subramaniam M; Keeney G L; Podratz K C; Spelsberg T C
The proto-oncogene c-fms is overexpressed in endometrial cancer.
Gynecologic oncology 1993;49(2):190-6.
1993: Cliby W; Ritland S; Hartmann L; Dodson M; Halling K C; Keeney G; Podratz K C; Jenkins R B
Human epithelial ovarian cancer allelotype.
Cancer research 1993;53(10 Suppl):2393-8.
1993: Podratz K C; Wilson T O; Gaffey T A; Cha S S; Katzmann J A
Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients.
American journal of obstetrics and gynecology 1993;168(4):1206-13; discussion 1213-5.
1993: Garton G R; Gunderson L L; Webb M J; Wilson T O; Martenson J A; Cha S S; Podratz K C
Intraoperative radiation therapy in gynecologic cancer: the Mayo Clinic experience.
Gynecologic oncology 1993;48(3):328-32.
1993: Podratz K C; Kinney W K
Second-look operation in ovarian cancer.
Cancer 1993;71(4 Suppl):1551-8.
1992: Hartmann L C; Sebo T J; Kamel N A; Podratz K C; Cha S S; Wieand H S; Keeney G L; Roche P C
Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survival.
Gynecologic oncology 1992;47(2):191-5.
1992: Hetzel D J; Wilson T O; Keeney G L; Roche P C; Cha S S; Podratz K C
HER-2/neu expression: a major prognostic factor in endometrial cancer.
Gynecologic oncology 1992;47(2):179-85.
1992: Zanetta G M; Katzmann J A; Keeney G L; Kinney W K; Cha S S; Podratz K C
Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma.
Gynecologic oncology 1992;46(1):13-9.
1992: Kinney W K; Egorshin E V; Ballard D J; Podratz K C
Long-term survival and sequelae after surgical management of invasive cervical carcinoma diagnosed at the time of simple hysterectomy.
Gynecologic oncology 1992;44(1):24-7.
1991: Lentz S S; Cha S S; Wieand H S; Podratz K C
Stage I ovarian epithelial carcinoma: survival analysis following definitive treatment.
Gynecologic oncology 1991;43(3):198-202.
1990: Stanhope C R; Webb M J; Podratz K C
Pelvic exenteration for recurrent cervical cancer.
Clinical obstetrics and gynecology 1990;33(4):897-909.
1990: Lentz S S; Kovach J S; McKean D J; Wieand H S; Podratz K C
Effector function of lymphokine-activated killer cells and cytotoxic T lymphocytes in ovarian epithelial carcinoma.
Gynecologic oncology 1990;38(2):191-6.
1990: Shaw E G; Gunderson L L; Martin J K; Beart R W; Nagorney D M; Podratz K C
Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990;18(3):247-55.
1990: Britton L C; Wilson T O; Gaffey T A; Cha S S; Wieand H S; Podratz K C
DNA ploidy in endometrial carcinoma: major objective prognostic factor.
Mayo Clinic proceedings. Mayo Clinic 1990;65(5):643-50.
1990: Wilson T O; Podratz K C; Gaffey T A; Malkasian G D; O'Brien P C; Naessens J M
Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma.
American journal of obstetrics and gynecology 1990;162(2):418-23; discussion 423-6.
1989: Alvarez R D; Soong S J; Kinney W K; Reid G C; Schray M F; Podratz K C; Morley G W; Shingleton H M
Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix.
Gynecologic oncology 1989;35(2):130-5.
1989: Britton L C; Wilson T O; Gaffey T A; Lieber M M; Wieand H S; Podratz K C
Flow cytometric DNA analysis of stage I endometrial carcinoma.
Gynecologic oncology 1989;34(3):317-22.
1989: Kinney W K; Alvarez R D; Reid G C; Schray M F; Soong S J; Morley G W; Podratz K C; Shingleton H M
Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study.
Gynecologic oncology 1989;34(3):258-62.
1989: Nielsen S N; Podratz K C; Scheithauer B W; O'Brien P C
Clinicopathologic analysis of uterine malignant mixed müllerian tumors.
Gynecologic oncology 1989;34(3):372-8.
1989: Lentz S S; McKean D J; Kovach J S; Podratz K C
Phenotypic and functional characteristics of mononuclear cells in ovarian carcinoma tumors.
Gynecologic oncology 1989;34(2):136-40.
1988: Schray M F; Martinez A; Howes A E; Podratz K C; Ballon S C; Malkasian G D; Sikic B I
Advanced epithelial ovarian cancer: salvage whole abdominal irradiation for patients with recurrent or persistent disease after combination chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(9):1433-9.
1988: Podratz K C; Schray M F; Wieand H S; Edmonson J H; Jefferies J A; Long H J; Malkasian G D; Stanhope C R; Wilson T O
Evaluation of treatment and survival after positive second-look laparotomy.
Gynecologic oncology 1988;31(1):9-24.
1988: Kinney W K; Egorshin E V; Podratz K C
Wertheim hysterectomy in the geriatric population.
Gynecologic oncology 1988;31(1):227-32.
1988: Malkasian G D; Knapp R C; Lavin P T; Zurawski V R; Podratz K C; Stanhope C R; Mortel R; Berek J S; Bast R C; Ritts R E
Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease.
American journal of obstetrics and gynecology 1988;159(2):341-6.
1988: Podratz K C; Malkasian G D; Wieand H S; Cha S S; Lee R A; Stanhope C R; Williams T J
Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma.
Gynecologic oncology 1988;29(3):274-82.
1987: Buskirk S J; Schray M F; Podratz K C; Lee R A; Stanhope C R; Gaffey T A; Weber F C; Earle J D; Naessens J M; Malkasian G D
Ovarian dysgerminoma: a retrospective analysis of results of treatment, sites of treatment failure, and radiosensitivity.
Mayo Clinic proceedings. Mayo Clinic 1987;62(12):1149-57.
1987: Schray M F; Podratz K C; Malkasian G D
Fallopian tube cancer: the role of radiation therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1987;10(4):267-75.
1987: Tsushima K; Podratz K C; Stanhope C R; Lieber M M
In vitro chemotherapy sensitivity testing of human ovarian carcinoma: comparison of optical colony counting and [3H]thymidine incorporation assays.
Gynecologic oncology 1987;28(2):170-80.
1987: Podratz K C; Symmonds R E; Hagen J V
Vesicovaginal fistulae.
Baillière's clinical obstetrics and gynaecology 1987;1(2):414-45.
1986: Malkasian G D; Podratz K C; Stanhope C R; Ritts R E; Zurawski V R
CA 125 in gynecologic practice.
American journal of obstetrics and gynecology 1986;155(3):515-8.
1986: Stanhope C R; Symmonds R E; Lee R A; Williams T J; Podratz K C; O'Brien P C
Urinary diversion with use of ileal and sigmoid conduits.
American journal of obstetrics and gynecology 1986;155(2):288-92.
1986: Podratz K C; Podczaski E S; Gaffey T A; O'Brien P C; Schray M F; Malkasian G D
Primary carcinoma of the fallopian tube.
American journal of obstetrics and gynecology 1986;154(6):1319-26.
1986: Schray M F; Martinez A; Howes A E; Ballon S C; Podratz K C; Sikic B I; Malkasian G D
Advanced epithelial ovarian cancer: toxicity of whole abdominal irradiation after operation, combination chemotherapy, and reoperation.
Gynecologic oncology 1986;24(1):68-80.
1985: Podratz K C; O'Brien P C; Malkasian G D; Decker D G; Jefferies J A; Edmonson J H
Effects of progestational agents in treatment of endometrial carcinoma.
Obstetrics and gynecology 1985;66(1):106-10.
1985: Podratz K C; Malkasian G D; Hilton J F; Harris E A; Gaffey T A
Second-look laparotomy in ovarian cancer: evaluation of pathologic variables.
American journal of obstetrics and gynecology 1985;152(2):230-8.
1983: Podratz K C; Gaffey T A; Symmonds R E; Johansen K L; O'Brien P C
Melanoma of the vulva: an update.
Gynecologic oncology 1983;16(2):153-68.
1983: Podratz K C; Symmonds R E; Taylor W F; Williams T J
Carcinoma of the vulva: analysis of treatment and survival.
Obstetrics and gynecology 1983;61(1):63-74.
1982: Podratz K C; Symmonds R E; Taylor W F
Carcinoma of the vulva: analysis of treatment failures.
American journal of obstetrics and gynecology 1982;143(3):340-51.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Karl Podratz

Research Profile (preview)

Concepts & Ideas

Disorders

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Karl Podratz (preview)

All Publications